Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released May 10, 2012, during market hours
10-Q filed May 10, 2012, 40 days after period end · 0001193125-12-224312
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $28.32M | $26.31M |
| Net Income | $529.00K | $1.68M |
| EPS Diluted | $0.02 | $0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 10, 2012 · 40 d after period end
